A world leading health company is seeking novel antibiotic-free microbial expression systems for production of a wide range of biologics including recombinant proteins, peptides, antigens, Fc-fusion proteins, and monoclonal antibodies. Additionally, the team is looking for partners and/or technologies to support removal of AMR genes from bacterial genomes through genetic modification.
Approaches of Interest:
- Bacterial or cell-based expression systems that are cost-effective, produce a high biologic yield and have scalable manufacturing capability are of...